The prevalence of type 2 diabetes mellitus in patients with autoimmune thyroiditis in hypothyroid stadium

Česká verzia

Authors: Štefan Sotak; Ivica Lazúrová; Marek Felšöci; Božena Nováková; Hedviga Wagnerová
Authors place of work: I. interná klinika LF UPJŠ a UN L. Pasteura Košice, Slovenská republika
Published in the journal: Vnitř Lék 2018; 64(3): 232-235
Category: Original Contributions

Summary

Introduction:
Autoimmune thyroiditis (AIT) and type 2 diabetes mellitus (DM2T) are the two most common endocrinological diseases worldwide. The relationship between T1DM and autoimmune thyreopathies is known and described, but the relationship between thyreopathies and diabetes type 2 is not clarified sufficiently through that studies manifest increasingly the connection between them.

Objective:
Investigate the prevalence of DM2T in patients with AIT in hypothyroid stadium and compare with common population and investigate a possible association between thyroid and glucose metabolism parameters.

Material and methods:
The group consisted of 100 patients (33 men and 67 women) with AIT without until now documented glucose metabolism disorder, average age 65.63 ± 19.05 years. The control group (CG) consisted of 100 subjects without until now documented thyreopathy and glucose metabolism disorder (37 men and 63 women), average age 63.85 ± 18.98 years. We realised venous blood sampling and determined thyroidal and glycid metabolism parameters.

Results:
The study did not confirm higher prevalence of diabetes in patients with AIT [3 (3 %) vs 4 (4 %), p = 1]. There were no statistical significant differences between glycid metabolism parameters in patients with AIT and CG. Also no glycid metabolism parameters correlated to thyroidal parameters.

Conclusion:
We did not confirm higher prevalence of DM in patients with AIT.

Key words:
autoimmune thyroiditis – diabetes mellitus type 2

Zdroje

1. Schroner Z, Lazúrová I, Petrovičová J. Autoimmune thyroid diseases in patients with diabetes mellitus. Bratisl Lek Listy 2008; 109(3): 125–129.

2. Hage M, Zantout, M Aznar S Thyroid Disorders and Diabetes Mellitus. J Thyroid Res 2011; 2011: 439463. Dostupné z DOI: <http://dx.doi.org/10.4061/2011/439463>.

3. Schroner Z, Uličiansky V. Diabetes mellitus a ochorenia štítnej žľazy. Forum Diab 2014; 3(3): 135–141.

4. Ittermann T, Markus MRP, Schipf S et al. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol 2013; 169(1): 9–15. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-13–0101>.

5. Gierach M, Gierach J, Skowrońska A et al. Hashimoto’s thyroiditis and carbohydrate metabolism disorders in patients hospitalised in the Department of Endocrinology and Diabetology of Ludwik Rydygier Collegium Medicum in Bydgoszcz between 2001 and 2010. Endokrynol Pol 2012; 63(1): 14–17.

6. Zamrazil V. Subklinické tyreopatie. Vnitř Lék 2007; 53(7–8): 795–798.

7. Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf) 2011; 75(1): 1–9. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365–2265.2011.04029.x>.

8. McCulloch AJ, Johnston DG, Baylis PH et al. Evidence that thyroid hormones regulate gluconeogenesis from glycerol in man. Clin Endocrinol (Oxf) 1983; 19(1): 67–76.

9. McDaniel HG, Pittman CS, Oh SJ et al. Carbohydrate metabolism in hypothyroid myopathy. Metabolism 1977; 26(8): 867–873.

10. Clausen N, Lins PE, Adamson U et al. Counterregulation of insulin-induced hypoglycaemia in primary hypothyroidism. Acta Endocrinol (Copenh) 1986; 111(4): 516–521.

11. Müller MJ, Seitz HJ. Interrelation between thyroid state and the effect of glucagon on gluconeogenesis in perfused rat livers. Biochem Pharmacol 1987; 36(10): 1623–1627.

12. Stanická S, Vondra K, Pelikánová T et al. Insulin sensitivity and counter-regulatory hormones in hypthyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 2005; 43(7): 715–720. Dostupné z DOI: <http://dx.doi.org/10.1515/CCLM.2005.121>.

13. Dimitriadis G, Mitrou P, Lambadiari V et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006; 91(12): 4930–4937. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2006–0478>.

14. Maratou E, Hadjidakis DJ, Kollias A et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009; 160(5): 785–790. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-08–0797>.

15. Dimitriadis G, Parry-Billings M, Bevan S et al. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 1997; 27(6): 475–483.

16. Rochon C, Tauveron I, Dejax C et al. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin Sci 2003; 104(1): 7–15. Dostupné z DOI: <http://dx.doi.org/10.1042/>.

17. Cettour-Rose P, Samec S, Russell AP et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes 2005; 54(3): 751–756.

18. Johnson AB, Webber J, Mansell P et al. Cardiovascular and metabolic responses to adrenaline infusion in patients with short term hypothyroidism. Clin Endocrinol (Oxf) 1995; 43(6): 747–751.

19. Kapadia KB, Bhatt PA, Shah JS. Association between altered thyroid state and insulin resistance. J Pharmacol Pharmacother 2012; 3(2): 156–160. Dostupné z DOI: <http://dx.doi.org/10.4103/0976–500X.95517>.

20. Ujwal Upadya B, Suma MN, Srinath KM et al. Effect of Insulin Resistance in Assessing the Clinical Outcome of Clinical and Subclinical Hypothyroid Patients. J Clin Diagn Res 2015; 9(2): OC01–4. Dostupné z DOI: <http://dx.doi.org/10.7860/JCDR/2015/9754.5513>.

21. Vyakaranam S, Vanaparthy S, Nori S et al. Study of Insulin Resistance in Subclinical Hypothyroidism. Int J Health Sci Res 2014; 4(9): 147–153.

22. Al-Shoumer KAS, Vasanthy BA, Al-Zaid MM. Effect of treatment of Hyperthyroidism on Glucose Homeostasis, Insulin Secretion, and Markers of Bone Turnover. Endocr Pract 2006; 12(2): 121–130. Dostupné z DOI: <http://dx.doi.org/10.4158/EP.12.2.121>.

23. Yasmin T, Ghafoor F, Malik T et al. Pattern of thyroid autoimmunity in type 1 and type 2 diabetics. J Coll Physicians Surg Pak 2006; 16(12): 751–754.

24. Tereshschenko IB, Suslina AA. Comparative analysis of the changing pattern of thyroid disease in patients with type 2 diabetes mellitus in the Perm region after 10 years. Ter Ark 2014; 86(10): 15–19.

25. Toulis K, Tsmekmekidou X, Potolidis E et al. Thyroid Autoimmunity in the Context of Type 2 Diabetes Mellitus: Implications for Vitamin D. Int J Endocrinol 2015; 2015: 710363. Dostupné z DOI: <http://dx.doi.org/10.1155/2015/710363>.